Judge Grants Class-Action Status to COVID-Sickened Prisoners

PORTLAND, Ore. (AP) — A federal judge has certified a class-action lawsuit in Oregon over state leaders’ response to the COVID-19 pandemic inside its prisons. A group of adults in custody who contracted COVID-19 first sued the state in April 2020, alleging culpability by Gov. Kate Brown, Corrections Department Director Colette Peters and Health Authority Director Patrick Allen, among other […]

Continue reading »

How worried should you be about BA.2?

The omicron variant swept around the globe, bringing a significant surge in COVID-19 cases and a resurgence of public health concerns about the pandemic a few months ago. That wave has long since receded, but the omicron variant of SARS-CoV-2 has further mutated. Now, after spurring another wave of cases in Europe, the BA.2 subvariant of the omicron variant of […]

Continue reading »

Whole of Shanghai Enters COVID Lockdown Despite Lower Symptomatic Cases

SHANGHAI (Reuters) – Chinese authorities on Tuesday extended a lockdown in Shanghai to cover all of the financial centre’s 26 million people, despite growing anger over quarantine rules in the city, where latest results show only 268 symptomatic daily COVID-19 cases. In a major test of China’s zero-tolerance strategy to eliminate the novel coronavirus, the government widened the lockdown to […]

Continue reading »

Novel Drug Offers New Hope for Rett Syndrome

Trofinetide (Acadia Pharmaceuticals) is effective in improving symptoms in girls and young women with Rett syndrome (RTT), a rare and devastating neurodevelopmental disorder, results from a phase 3 study suggest. Dr Jeffrey Neul “In a severe disorder like Rett syndrome that has no approved therapies and where all of our interventions are purely symptomatic, it’s very exciting to be at […]

Continue reading »

US Pulls COVID Drug as Omicron Subvariant Spreads

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Federal regulators announced Tuesday that GlaxoSmithKline’s COVID-19 drug should no longer be used because it’s likely ineffective against BA.2, the Omicron subvariant that now accounts for most new cases in the U.S., the Associated Press reports. The FDA announced that the antibody drug sotrovimab is no […]

Continue reading »

Study validates first tool to utilize caregiver input to assess post-ICU syndrome symptoms

A new study from Regenstrief Institute and Indiana University School of Medicine validates the caregiver version of the Healthy Aging Brain Care Monitor as an accurate, dynamic tool for monitoring the burden of post-intensive care unit (ICU) symptoms among ICU survivors through their caregiver’s input and for providing clinically relevant information on new or changing physical, mental and emotional symptoms […]

Continue reading »

Americans report mental health effects of climate change, worry about future

According to the latest Healthy Minds Monthly poll from the American Psychiatric Association (APA), 58% of adults believe climate change is already impacting the health of Americans and nearly half (48%) agree that it’s impacting the mental health of Americans. Half of adults (51%) are anxious about climate change’s impact on future generations. Among the 2,210 adults in a nationally […]

Continue reading »
1 492 493 494 495 496 1,322